Get started Log in

VERV — Verve Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
$992.16m
Enterprise Value
$495.09m
Revenue
$32.33m

U.S. STOCKS ON THE MOVE-HP, Digital World Acquisition, Guardant Health
13/11/2023 14:21
U.S. STOCKS ON THE MOVE-Boeing, Verve, Aclaris
13/11/2023 13:18
Verve Therapeutics slumps on questions over gene editing therapy data
13/11/2023 12:04
Brief: Verve Therapeutics' Cash, Cash Equivalents And Marketable Securities Of $485.2 Million With Cash Runway Into 2026
07/11/2023 11:38
Brief: Verve Therapeutics Q3 EPS USD -0.72
07/11/2023 11:38
Beam climbs on Lilly deal for opt-in rights to gene-editing program
31/10/2023 12:40
Brief: Verve Therapeutics And Lilly Relationship Expands To Include Verve's In Vivo Gene Editing Programs Targeting PCSK9 And ANGPTL3
31/10/2023 10:33
U.S. STOCKS ON THE MOVE-LumiraDx, Navios Maritime, Spirit AeroSystems
23/10/2023 16:33
U.S. STOCKS ON THE MOVE-Alcoa, Harpoon, EngageSmart
23/10/2023 13:56
Verve rises as FDA lifts clinical hold on trial for lead gene editing therapy
23/10/2023 12:42
Brief: Verve Therapeutics Says Investigational New Drug Application For VERVE-101 Cleared by U.S. FDA
23/10/2023 12:27
Brief: Verve Therapeutics Q2 EPS USD -0.87
10/08/2023 11:33
U.S. STOCKS ON THE MOVE-Premier, Canadian Solar, Jabil
15/06/2023 17:42
U.S. STOCKS ON THE MOVE-Premier, Canadian Solar, Jabil
15/06/2023 17:27
Verve Therapeutics rises on research deal with Eli Lilly
15/06/2023 14:56
Brief: Verve Therapeutics, Lilly Entered Into Stock Purchase Agreement For Sale
15/06/2023 11:57
Brief: Verve Establishes Global Collaboration With Lilly
15/06/2023 11:51
Obesity fighting success fuels Novo bet on gene-editing tech
24/05/2023 11:00
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
16/05/2023 07:43
Brief: Verve Therapeutics Announces Pipeline Progress And Expansion
15/05/2023 11:45